Drug Type Induced pluripotent stem cells (iPSC) |
Synonyms- |
Target |
Action stimulants |
Mechanism VEGF-A stimulants(Vascular endothelial growth factor A stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Kidney Injury | Preclinical | United States | 02 Apr 2025 | |
| Acute Kidney Injury | Preclinical | Japan | 02 Apr 2025 | |
| Chronic Kidney Diseases | Preclinical | United States | 02 Apr 2025 | |
| Chronic Kidney Diseases | Preclinical | Japan | 02 Apr 2025 |





